Finance

Beta
Lists
0853:HKG
MicroPort Scientific Corp
HK$7.16
0.00%
(0.00) 1D
Jun 5, 4:09:10 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 0853...
Open
HK$7.27
High
HK$7.27
Low
HK$7.07
Mkt. cap
13.82B
Avg. vol.
12.03M
Volume
10.96M
52-wk high
HK$16.28
52-wk low
HK$7.07
EPS
-HK$0.98
Shares outstanding
1.60B
No. of employees
7K
Open
HK$7.27
High
HK$7.27
Low
HK$7.07
Mkt. cap
13.82B
Avg. vol.
12.03M
Volume
10.96M
52-wk high
HK$16.28
52-wk low
HK$7.07
EPS
-HK$0.98
Shares outstanding
1.60B
No. of employees
7K
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to 0853 in the past 3 months
Strong Buy
Buy
4
Hold
1
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for 0853 in the last 3 months.
Highest
Current HK$7.16
HK$18.00 (+151.40%)
Average
HK$14.96 (+108.92%)
Lowest
HK$10.50 (+46.65%)
News stories
From sources across the web
Profile
MicroPort is a multinational medical technology company with headquarters in Shanghai; Irvine, California; and Clamart, France. The company designs and produces medical devices across multiple therapeutic areas including interventional cardiology, orthopedics, cardiac rhythm management, electrophysiology, neurovascular intervention, structural heart disease, surgical robotics, and critical care. MicroPort completed its initial public offering on the Hong Kong Stock Exchange in 2010 and has since established multiple specialized subsidiaries focused on distinct therapeutic areas, with several completing separate public listings. Recognized as one of the global Medtech Big 100 companies, MicroPort's coronary intervention products have been implanted in over 10 million patients globally since its founding, with devices distributed globally in over 90 countries across. Wikipedia
About MicroPort Scientific Corp
CEOJonathan H. Chou
Employees6.55K
Founded1998
Headquarters-
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
273.77M
273.77M
278.92M
278.92M
Cost of goods sold
119.48M
119.48M
115.92M
115.92M
Cost of revenue
119.48M
119.48M
115.92M
115.92M
Research and development expenses
36.04M
36.04M
37.21M
37.21M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
115.67M
115.67M
128.21M
128.21M
Operating expense
153.68M
153.68M
181.85M
181.85M
Total operating expenses
273.16M
273.16M
297.77M
297.77M
Operating income
606.50K
606.50K
-18.85M
-18.85M
Other non operating income
9.50M
9.50M
557.00K
557.00K
EBT including unusual items
-9.72M
-9.72M
47.94M
47.94M
EBT excluding unusual items
-6.70M
-6.70M
-56.66M
-56.66M
Income tax expense
8.46M
8.46M
10.54M
10.54M
Effective tax rate
-86.95%
-86.95%
21.99%
21.99%
Other operating expenses
1.97M
1.97M
13.81M
13.81M
Net income
-23.30M
-23.30M
47.56M
47.56M
Net profit margin
-8.51%
-8.51%
17.05%
17.05%
Earnings per share
-
-
-
-
Interest and investment income
4.34M
4.34M
4.02M
4.02M
Interest expense
-28.41M
-28.41M
-25.00M
-25.00M
Net interest expenses
-24.06M
-24.06M
-20.99M
-20.99M
Depreciation and amortization charges
-
-
-
-
EBITDA
26.04M
26.04M
1.04M
1.04M
Gain or loss from assets sale
-
-
-165.23M
-165.23M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more